Please Wait

Applying Filters...

CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

PIPERACILLIN; TAZOBACTAM

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 14 USDMF, 14 CEP/COS, 13 JDMF, 1 EU WC, 10 KDMF, 13 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

245 FDF Dossiers, 70 FDA Orange Book, 121 Europe, 15 South Africa, 39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML, INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML, INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 Kirsch Pharma, 1 Actylis, 4 Roquette

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 2 Fillers, Diluents & Binders, 1 Thickeners and Stabilizers, 1 API Stability Enhancers

DIGITAL CONTENT

33 News #PharmaBuzz

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 40 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

7 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 11 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/10/2025	Fresenius Kabi AB Brunna	Sweden	Sangjin Trading Co., Ltd.	20190829-95-E-153-07	piperacillin hydrate	2019-08-29	Fresenius Kabi IPSUM SRL	Italy	Via San Leonardo, 23 – 45010 VILLADOSE (RO), Italy
31/10/2025	Fresenius Kabi AB Brunna	Sweden	Chong Kun Dang Co., Ltd.	20120814-95-E-98-02(3)	piperacillin sodium	2017-09-01	Fresenius Kabi iPSUM Srl	Italy	Via A. Boito, 13 I-20053 Taccona Di Muggio (MB) (Synthetic manufacturer: Via S. Leonardo, 23 1-45010 Villadose (RO), Italy)

Contact us
to update this info

PIPERACILLIN; TAZOBACTAM

PIPERACILLIN; TAZOBACTAM

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

47 API Suppliers

14 USDMF

14 CEP/COS

13 JDMF

1 EU WC

10 KDMF

13 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

245 FDF Dossiers

70 FDA Orange Book

121 Europe

15 South Africa

39 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML

INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML

INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

3 Kirsch Pharma

1 Actylis

4 Roquette

EXCIPIENTS BY APPLICATIONS

6 Parenteral

2 Fillers, Diluents & Binders

1 Thickeners and Stabilizers

1 API Stability Enhancers

DIGITAL CONTENT

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions

40 Regulatory FDF Prices

7 Annual Reports

MARKET PLACE

7 APIs

5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM

4 USP

11 Others

Filters

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons